4 hours ago
Description
(AWP Alliance News) - Galderma agreed to buy physician-dispensed skincare brand ZO Skin Health for an enterprise value of USD 1.5 billion in an all-cash deal. ZO Skin Health, founded by dermatologist Zein Obagi, is owned by shareholders including funds managed by Blackstone Tactical Opportunities and the Obagi family.
The target generated about USD 330 million of net sales in the 12 months through June 2026, supported by more than 16,500 physician, medical spa, and online accounts across more than 40 countries. Galderma expects the deal to close in Q4 2026 or early 2027 and fund it with a mix of cash on hand and bank financing.
The acquisition expands Galderma's dermatological skincare portfolio, adding ZO's regimen-based products alongside brands such as Cetaphil and Alastin.
https://www.businesswire.com/news/home/20261013945338/en/
Disclaimer: This news brief was created using generative artificial intelligence. Galderma Group AG published the original content used to generate this news brief via Business Wire on October 14, 2026, and is solely responsible for the information contained therein.
